MoneyWorks4Me

Granules India submits disclosures

04 Jun 2014 Evaluate

Granules India has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992

The above information is a part of company’s filings submitted to BSE.

 

 

Granules India Share Price

840.00 7.45 (0.89%)
28-Aug-2026 12:49 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1918.55
Dr. Reddys Labs. 1182.05
Cipla 1414.00
Lupin 2167.45
Zydus Lifesciences 1179.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: